Clinical trial
Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery…
NCT00123539 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Terminated
Key facts
| NCT number | NCT00123539 |
|---|---|
| Title | Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery |
| Official title | Estradiol for Neurocognitive Dysfunction After CABG |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Coronary Disease, Cardiovascular Diseases, Heart Diseases, Neurologic Manifestations |
| Intervention type | Drug, Procedure |
| Interventions | Estrogen Replacement Therapy, Surgery |
| Enrollment | 334 |
| Start date | Jun 1, 2001 |
| Completion | Aug 1, 2005 |
| First posted | Jul 25, 2005 |
| Last update posted | Jul 29, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: